Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study ; volume:8 ; number:1 ; day:27 ; month:1 ; year:2007 ; pages:1-10 ; date:12.2007
Respiratory research ; 8, Heft 1 (27.1.2007), 1-10, 12.2007
- Urheber
-
Goletti, Delia
- Beteiligte Personen und Organisationen
-
Parracino, M Pasquale
Butera, Ornella
Bizzoni, Federica
Casetti, Rita
Dainotto, Duilio
Anzidei, Gianfranco
Nisii, Carla
Ippolito, Giuseppe
Poccia, Fabrizio
Girardi, Enrico
SpringerLink (Online service)
- DOI
-
10.1186/1465-9921-8-5
- URN
-
urn:nbn:de:1111-201606037834
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Goletti, Delia
- Parracino, M Pasquale
- Butera, Ornella
- Bizzoni, Federica
- Casetti, Rita
- Dainotto, Duilio
- Anzidei, Gianfranco
- Nisii, Carla
- Ippolito, Giuseppe
- Poccia, Fabrizio
- Girardi, Enrico
- SpringerLink (Online service)
Ähnliche Objekte (12)
Joining attention to see differently
Bifidobacterium adolescentis is resistant to pyrazinamide, isoniazid, and streptomycin
Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity
Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis
Things one would wish to have expressed differently
Kinesin and dynein respond differently to cytoplasmic drag
So sehen und anders sehen : = To seee and to see differently
Approaches to Target Conserved Conformational Epitopes in HIV Envelope
Gaining access to the sterically occluded CD4-induced epitopes
Engineered immunogens to elicit antibodies against conserved coronavirus epitopes
PEPOP 2.0: new approaches to mimic non-continuous epitopes
Joining attention to see differently
Bifidobacterium adolescentis is resistant to pyrazinamide, isoniazid, and streptomycin
Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity
Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis
Things one would wish to have expressed differently
Kinesin and dynein respond differently to cytoplasmic drag
So sehen und anders sehen : = To seee and to see differently
Approaches to Target Conserved Conformational Epitopes in HIV Envelope
Gaining access to the sterically occluded CD4-induced epitopes
Engineered immunogens to elicit antibodies against conserved coronavirus epitopes
PEPOP 2.0: new approaches to mimic non-continuous epitopes
Joining attention to see differently
Bifidobacterium adolescentis is resistant to pyrazinamide, isoniazid, and streptomycin
Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity
Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis
Things one would wish to have expressed differently
Kinesin and dynein respond differently to cytoplasmic drag
So sehen und anders sehen : = To seee and to see differently
Approaches to Target Conserved Conformational Epitopes in HIV Envelope
Gaining access to the sterically occluded CD4-induced epitopes
Engineered immunogens to elicit antibodies against conserved coronavirus epitopes